LIBREVILLE, Gabon — On July 25, 2026, the President of the Conseil économique, social, environnemental et culturel (CESEC), Guy Bertrand Mapangou, led a delegation on a visit to the struggling pharmaceutical plant in the Zone économique à régime privilégié (ZERP) of Nkok, near the capital, Libreville.
The visit, which included American researchers, aimed to understand the plant’s operations and address the ongoing crisis that threatens its production. Established in November 2020 by Indian investors, the plant has been facing challenges that could disrupt its activities. CESEC’s engagement in the matter is part of a broader advocacy for health sovereignty, a theme that was highlighted during the recent meeting of the Union des Conseils économiques et sociaux d’Afrique.
Mapangou emphasized the importance of preserving the pharmaceutical unit, which could contribute to Gabon’s autonomy in the production of medicines and cater to the entire CEMAC region.
The visit is a precursor to the upcoming session in September, which will focus on health sovereignty issues.
The plant, La Santé Pharmaceutique, has been addressing financial difficulties since its inception. Despite an agreement with the Banque des États d’Afrique Centrale (BDEAC) and Orabank Gabon in 2022 for a loan to expand its production unit, the company has faced operational inefficiencies.
The CESEC’s commitment to finding solutions to the plant’s financial crisis is a significant step towards addressing the challenges faced by La Santé Pharmaceutique and, by extension, Gabon’s pharmaceutical sector.
The visit by the CESEC President is a critical moment for the plant and the nation’s health security, as well as for the broader African continent’s economic development.
*Additional reporting by ImNews | Sources consulted: 5*
—
This original article was produced by the ImNews editorial team
Source: Agpgabon
Source: Redaction
